Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models

被引：6
|
作者：
Ji, H
Li, SP
Cheng, X
Cheng, HR
Ng, TB
Li, P
Li, NS
机构：
[1] China Pharmaceut Univ, Dept Pharmacol, Nanjing 210009, Peoples R China
[2] Chinese Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China
[3] Hefei Siu Fung USTC Pharmaceut Co Ltd, Hefei, Peoples R China
[4] China Pharmaceut Univ, Dept Pharmacognosy, Nanjing 210009, Peoples R China
来源：
GENERAL PHARMACOLOGY | 1999年 / 33卷 / 02期
关键词：
low-molecular-weight heparin; heparin; antithrombotic agent;
D O I：
10.1016/S0306-3623(98)00276-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The antithrombotic activity of low-molecular-weight heparin calcium (LMWH-Ca) was studied in venous and arterial thrombosis models, arterial thrombosis model in rats, arterio-venous shunt model and venous thrombosis model. in rabbits. The data showed that LMWH-Ca reduced thrombus formation in a dose-dependent manner. It suggests that LMWH-Ca is a potent antithrombotic agent for venous thrombosis, and also may be a beneficial therapeutic agent in arterial thrombosis. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码：207 / 211
页数：5
相关论文
共 50 条
  • [31] HEPARIN AND ITS LOW-MOLECULAR-WEIGHT DERIVATIVES - ANTICOAGULANT AND ANTITHROMBOTIC PROPERTIES
    HOLMER, E
    SODERBERG, K
    BERGQVIST, D
    LINDAHL, U
    HAEMOSTASIS, 1986, 16 : 1 - 7
  • [32] EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH) ON COAGULATION AND PLATELET ACTIVATION AT THE SITE OF PLUG FORMATION
    EICHINGER, S
    NIESZPAURLOS, M
    SCHNEIDER, B
    WOLZT, M
    PABINGER, I
    EICHLER, HG
    LECHNER, K
    KYRLE, PA
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 861 - 861
  • [33] COMPARISON OF THE ANTICLOTTING AND ANTITHROMBOTIC ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN WITH PORCINE MUCOSAL HEPARIN
    CARMINT, W
    SMALL, B
    WILLIS, J
    FENICHEL, R
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 424 - 424
  • [34] Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Hirsh, J
    Raschke, R
    CHEST, 2004, 126 (03) : 188S - 203S
  • [35] The effects of low-molecular-weight heparin on trophoblasts
    Rimon, E.
    Kupferminc, M.
    THROMBOSIS RESEARCH, 2013, 131 : S102 - S102
  • [36] Heparin calcium and low-molecular-weight heparin: a study for just prescription
    Pouderoux, I.
    Karakurt, E.
    Vergano, M.
    Badibouidi, F.
    Verbrigghe, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (05) : 1389 - 1389
  • [37] ANTITHROMBOTIC AND ANTI-THROMBOLYTIC EFFECTS OF LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS AND HEPARIN IN RAT ARTERIOVENOUS SHUNT MODELS
    TAPPARELLI, C
    METTERNICH, R
    GAFNER, B
    GFELLER, P
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1323 - 1323
  • [38] IS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AN EFFECTIVE ANTITHROMBOTIC DRUG FOLLOWING HIP FRACTURE SURGERY - RESULTS OF A RANDOMIZED STUDY COMPARING LMWH AND DEXTRAN-70
    FALKENDAL, L
    ERIKSSON, BI
    SODERBERG, K
    KALEBO, P
    JARNEBORN, L
    RISBERG, B
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 977 - 977
  • [39] Heparin and low-molecular-weight heparin
    Gray, Elaine
    Mulloy, Barbara
    Barrowcliffel, Trevor W.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 807 - 818
  • [40] COMPARISON OF THE ANTITHROMBOTIC EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINOID KB-101 AND HEPARIN IN A RAT EXPERIMENTAL-MODEL
    SUEHIRO, A
    IMAOKA, J
    KAKISHITA, E
    GENERAL PHARMACOLOGY, 1993, 24 (02): : 341 - 344
12345